氢氯噻嗪 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "氢氯噻嗪" in Chinese language version.
refsWebsite
Global rank
Chinese rank
11th place
332nd place
1st place
1st place
3,912th place
5,917th place
3rd place
8th place
102nd place
492nd place
4,720th place
8,539th place
6th place
4th place
3,984th place
1,603rd place
3,733rd place
2,689th place
2,393rd place
1,199th place
1,581st place
1,717th place
9,542nd place
9,880th place
archive.org
- Lacourcière Y, Poirier L. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension. American Journal of Hypertension. December 2003, 16 (12): 1036–1042. PMID 14643578. S2CID 26447230. doi:10.1016/j.amjhyper.2003.07.014
.
books.google.com
- Ravina E. The evolution of drug discovery: from traditional medicines to modern drugs 1st. Weinheim: Wiley-VCH. 2011: 74. ISBN 9783527326693. （原始内容存档于10 January 2015）.
clincalc.com
- The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
- Hydrochlorothiazide Drug Usage Statistics, United States, 2013 - 2022. ClinCalc. [2024-08-30].
consumerreports.org
- Best drugs to treat high blood pressure The least expensive medications may be the best for many people. November 2014 [2015-01-10]. （原始内容存档于2015-01-03）.
doi.org
- Beermann B, Groschinsky-Grind M, Rosén A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clinical Pharmacology and Therapeutics. May 1976, 19 (5 Pt 1): 531–537. PMID 1277708. S2CID 22159706. doi:10.1002/cpt1976195part1531.
- Wright JM, Musini VM, Gill R. First-line drugs for hypertension. The Cochrane Database of Systematic Reviews. April 2018, 2018 (4): CD001841. PMC 6513559 . PMID 29667175. doi:10.1002/14651858.CD001841.pub3.
- Duarte JD, Cooper-DeHoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Review of Cardiovascular Therapy. June 2010, 8 (6): 793–802. PMC 2904515 . PMID 20528637. doi:10.1586/erc.10.27. NIHMSID: NIHMS215063.
- Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. November 2019, 394 (10211): 1816–1826. PMC 6924620 . PMID 31668726. doi:10.1016/S0140-6736(19)32317-7.
- Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM. Pharmacotherapy for hypertension in adults aged 18 to 59 years. The Cochrane Database of Systematic Reviews. August 2017, 2017 (8): CD008276. PMC 6483466 . PMID 28813123. doi:10.1002/14651858.CD008276.pub2. 已忽略未知参数
|collaboration=(帮助) - Hripcsak G, Suchard MA, Shea S, Chen R, You SC, Pratt N, et al. Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension. JAMA Internal Medicine. April 2020, 180 (4): 542–551. PMC 7042845 . PMID 32065600. doi:10.1001/jamainternmed.2019.7454.
- Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension. June 2012, 59 (6): 1104–1109. PMC 4930655 . PMID 22547443. doi:10.1161/HYPERTENSIONAHA.111.190637.
- Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. April 2011, 57 (4): 689–694. PMID 21383313. S2CID 13017777. doi:10.1161/HYPERTENSIONAHA.110.161505 .
- Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, et al. Long-term follow-up of patients with hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. December 2012, 97 (12): 4507–4514. PMC 3513540 . PMID 23043192. doi:10.1210/jc.2012-1808.
- Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. The Cochrane Database of Systematic Reviews. October 2011, (10): CD005185. PMID 21975748. doi:10.1002/14651858.CD005185.pub2. 已忽略未知参数
|collaboration=(帮助) - Xiao X, Xu Y, Wu Q. Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies. Osteoporosis International. July 2018, 29 (7): 1515–1524. PMID 29574519. S2CID 4322516. doi:10.1007/s00198-018-4486-9.
- Solomon DH, Ruppert K, Zhao Z, Lian YJ, Kuo IH, Greendale GA, Finkelstein JS. Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study. Osteoporosis International. March 2016, 27 (3): 1181–1189. PMC 4813302 . PMID 26449354. doi:10.1007/s00198-015-3332-6.
- Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. Journal of the American Society of Nephrology. September 2007, 18 (9): 2509–2516. PMC 2216427 . PMID 17656470. doi:10.1681/ASN.2007030348.
- Lacourcière Y, Poirier L. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension. American Journal of Hypertension. December 2003, 16 (12): 1036–1042. PMID 14643578. S2CID 26447230. doi:10.1016/j.amjhyper.2003.07.014 .
- Musini VM, Nazer M, Bassett K, Wright JM. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. The Cochrane Database of Systematic Reviews. May 2014, 2014 (5): CD003824. PMC 10612990 . PMID 24869750. doi:10.1002/14651858.cd003824.pub2.
- Hueskes BA, Roovers EA, Mantel-Teeuwisse AK, Janssens HJ, van de Lisdonk EH, Janssen M. Use of diuretics and the risk of gouty arthritis: a systematic review. Seminars in Arthritis and Rheumatism. June 2012, 41 (6): 879–889. PMID 22221907. doi:10.1016/j.semarthrit.2011.11.008.
- Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. Journal of Clinical Hypertension. December 2014, 16 (12): 864–868. PMC 8031516 . PMID 25258088. doi:10.1111/jch.12413 .
- Johnson KK, Green DL, Rife JP, Limon L. Sulfonamide cross-reactivity: fact or fiction?. The Annals of Pharmacotherapy. February 2005, 39 (2): 290–301. PMID 15644481. S2CID 10642527. doi:10.1345/aph.1E350.
- Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. The New England Journal of Medicine. October 2003, 349 (17): 1628–1635. PMID 14573734. doi:10.1056/NEJMoa022963 .
- Ghimire S, Kyung E, Lee JH, Kim JW, Kang W, Kim E. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. Journal of Clinical Pharmacy and Therapeutics. June 2013, 38 (3): 196–202. PMID 23489131. doi:10.1111/jcpt.12048 .
- Pedersen SA, Gaist D, Schmidt SA, Hölmich LR, Friis S, Pottegård A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology. April 2018, 78 (4): 673–681.e9. PMID 29217346. doi:10.1016/j.jaad.2017.11.042 .
- Cogliano VJ, Corsini E, Fournier A, Nelson HH, Sergi CM, Antunes AMM; et al. Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus. The Lancet Oncology. 2024-11-29, 26 (1): 15–16. doi:10.1016/S1470-2045(24)00685-5.
drugs.com
- Hydrochlorothiazide Use During Pregnancy. Drugs.com. 2019-07-30 [2020-01-19].
- Hydrochlorothiazide. Drugs.com. 2022-11-15 [2023-05-31].
europa.eu
ema.europa.eu
- List of nationally authorised medicinal products : Active substance: bisoprolol / hydrochlorothiazide Procedure no.: PSUSA/00000420/202111 (PDF). Ema.europa.eu. [202-07-162].
fda.gov
- FDA approves label changes to hydrochlorothiazide. U.S. Food and Drug Administration (FDA). 2020-08-20 [2020-08-28].
本文含有此來源中屬於公有领域的内容。
handle.net
hdl.handle.net
- World Health Organization. The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. 2023. hdl:10665/371090 . WHO/MHP/HPS/EML/2023.02.
healthline.com
- Highlights for hydrochlorothiazide-valsartan. healthline. [2025-02-12].
medlineplus.gov
- Triamterene and Hydrochlorothiazide. MedlinePlus. 2020-01-01 [2020-01-01]. （原始内容存档于2020-01-02）.
nih.gov
ncbi.nlm.nih.gov
- Beermann B, Groschinsky-Grind M, Rosén A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clinical Pharmacology and Therapeutics. May 1976, 19 (5 Pt 1): 531–537. PMID 1277708. S2CID 22159706. doi:10.1002/cpt1976195part1531.
- Wright JM, Musini VM, Gill R. First-line drugs for hypertension. The Cochrane Database of Systematic Reviews. April 2018, 2018 (4): CD001841. PMC 6513559 . PMID 29667175. doi:10.1002/14651858.CD001841.pub3.
- Duarte JD, Cooper-DeHoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Review of Cardiovascular Therapy. June 2010, 8 (6): 793–802. PMC 2904515 . PMID 20528637. doi:10.1586/erc.10.27. NIHMSID: NIHMS215063.
- Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. November 2019, 394 (10211): 1816–1826. PMC 6924620 . PMID 31668726. doi:10.1016/S0140-6736(19)32317-7.
- Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM. Pharmacotherapy for hypertension in adults aged 18 to 59 years. The Cochrane Database of Systematic Reviews. August 2017, 2017 (8): CD008276. PMC 6483466 . PMID 28813123. doi:10.1002/14651858.CD008276.pub2. 已忽略未知参数
|collaboration=(帮助) - Hripcsak G, Suchard MA, Shea S, Chen R, You SC, Pratt N, et al. Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension. JAMA Internal Medicine. April 2020, 180 (4): 542–551. PMC 7042845 . PMID 32065600. doi:10.1001/jamainternmed.2019.7454.
- Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension. June 2012, 59 (6): 1104–1109. PMC 4930655 . PMID 22547443. doi:10.1161/HYPERTENSIONAHA.111.190637.
- Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. April 2011, 57 (4): 689–694. PMID 21383313. S2CID 13017777. doi:10.1161/HYPERTENSIONAHA.110.161505 .
- Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, et al. Long-term follow-up of patients with hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. December 2012, 97 (12): 4507–4514. PMC 3513540 . PMID 23043192. doi:10.1210/jc.2012-1808.
- Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. The Cochrane Database of Systematic Reviews. October 2011, (10): CD005185. PMID 21975748. doi:10.1002/14651858.CD005185.pub2. 已忽略未知参数
|collaboration=(帮助) - Xiao X, Xu Y, Wu Q. Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies. Osteoporosis International. July 2018, 29 (7): 1515–1524. PMID 29574519. S2CID 4322516. doi:10.1007/s00198-018-4486-9.
- Solomon DH, Ruppert K, Zhao Z, Lian YJ, Kuo IH, Greendale GA, Finkelstein JS. Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study. Osteoporosis International. March 2016, 27 (3): 1181–1189. PMC 4813302 . PMID 26449354. doi:10.1007/s00198-015-3332-6.
- Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. Journal of the American Society of Nephrology. September 2007, 18 (9): 2509–2516. PMC 2216427 . PMID 17656470. doi:10.1681/ASN.2007030348.
- Lacourcière Y, Poirier L. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension. American Journal of Hypertension. December 2003, 16 (12): 1036–1042. PMID 14643578. S2CID 26447230. doi:10.1016/j.amjhyper.2003.07.014 .
- Musini VM, Nazer M, Bassett K, Wright JM. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. The Cochrane Database of Systematic Reviews. May 2014, 2014 (5): CD003824. PMC 10612990 . PMID 24869750. doi:10.1002/14651858.cd003824.pub2.
- Hueskes BA, Roovers EA, Mantel-Teeuwisse AK, Janssens HJ, van de Lisdonk EH, Janssen M. Use of diuretics and the risk of gouty arthritis: a systematic review. Seminars in Arthritis and Rheumatism. June 2012, 41 (6): 879–889. PMID 22221907. doi:10.1016/j.semarthrit.2011.11.008.
- Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. Journal of Clinical Hypertension. December 2014, 16 (12): 864–868. PMC 8031516 . PMID 25258088. doi:10.1111/jch.12413 .
- Johnson KK, Green DL, Rife JP, Limon L. Sulfonamide cross-reactivity: fact or fiction?. The Annals of Pharmacotherapy. February 2005, 39 (2): 290–301. PMID 15644481. S2CID 10642527. doi:10.1345/aph.1E350.
- Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. The New England Journal of Medicine. October 2003, 349 (17): 1628–1635. PMID 14573734. doi:10.1056/NEJMoa022963 .
- Ghimire S, Kyung E, Lee JH, Kim JW, Kang W, Kim E. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. Journal of Clinical Pharmacy and Therapeutics. June 2013, 38 (3): 196–202. PMID 23489131. doi:10.1111/jcpt.12048 .
- Pedersen SA, Gaist D, Schmidt SA, Hölmich LR, Friis S, Pottegård A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Journal of the American Academy of Dermatology. April 2018, 78 (4): 673–681.e9. PMID 29217346. doi:10.1016/j.jaad.2017.11.042 .
semanticscholar.org
api.semanticscholar.org
- Beermann B, Groschinsky-Grind M, Rosén A. Absorption, metabolism, and excretion of hydrochlorothiazide. Clinical Pharmacology and Therapeutics. May 1976, 19 (5 Pt 1): 531–537. PMID 1277708. S2CID 22159706. doi:10.1002/cpt1976195part1531.
- Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension. April 2011, 57 (4): 689–694. PMID 21383313. S2CID 13017777. doi:10.1161/HYPERTENSIONAHA.110.161505 .
- Xiao X, Xu Y, Wu Q. Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies. Osteoporosis International. July 2018, 29 (7): 1515–1524. PMID 29574519. S2CID 4322516. doi:10.1007/s00198-018-4486-9.
- Lacourcière Y, Poirier L. Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension. American Journal of Hypertension. December 2003, 16 (12): 1036–1042. PMID 14643578. S2CID 26447230. doi:10.1016/j.amjhyper.2003.07.014 .
- Johnson KK, Green DL, Rife JP, Limon L. Sulfonamide cross-reactivity: fact or fiction?. The Annals of Pharmacotherapy. February 2005, 39 (2): 290–301. PMID 15644481. S2CID 10642527. doi:10.1345/aph.1E350.
tga.gov.au
- Hydrochlorothiazide. Therapeutic Goods Administration (TGA). 2020-08-24 [2020-09-22].
thelancet.com
- Cogliano VJ, Corsini E, Fournier A, Nelson HH, Sergi CM, Antunes AMM; et al. Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus. The Lancet Oncology. 2024-11-29, 26 (1): 15–16. doi:10.1016/S1470-2045(24)00685-5.
wada-ama.org
- Prohibited List (PDF). World Anti-Doping Agency. January 2018.
web.archive.org
- Ravina E. The evolution of drug discovery: from traditional medicines to modern drugs 1st. Weinheim: Wiley-VCH. 2011: 74. ISBN 9783527326693. （原始内容存档于10 January 2015）.
- Best drugs to treat high blood pressure The least expensive medications may be the best for many people. November 2014 [2015-01-10]. （原始内容存档于2015-01-03）.
- The Top 300 of 2022. ClinCalc. [2024-08-30]. （原始内容存档于2024-08-30）.
- Triamterene and Hydrochlorothiazide. MedlinePlus. 2020-01-01 [2020-01-01]. （原始内容存档于2020-01-02）.